nodes	percent_of_prediction	percent_of_DWPC	metapath
Bexarotene—Thyroid disorder—Octreotide—thymus cancer	0.063	0.0631	CcSEcCtD
Bexarotene—Abnormal faeces—Octreotide—thymus cancer	0.0362	0.0362	CcSEcCtD
Bexarotene—Varicose vein—Octreotide—thymus cancer	0.0278	0.0278	CcSEcCtD
Bexarotene—Rectal tenesmus—Octreotide—thymus cancer	0.0278	0.0278	CcSEcCtD
Bexarotene—Hypochromic anaemia—Octreotide—thymus cancer	0.0267	0.0267	CcSEcCtD
Bexarotene—Pancreatitis acute—Octreotide—thymus cancer	0.0224	0.0224	CcSEcCtD
Bexarotene—Proctalgia—Octreotide—thymus cancer	0.0221	0.0221	CcSEcCtD
Bexarotene—Ear disorder—Octreotide—thymus cancer	0.0192	0.0192	CcSEcCtD
Bexarotene—Anorectal discomfort—Octreotide—thymus cancer	0.0189	0.0189	CcSEcCtD
Bexarotene—Cholecystitis—Octreotide—thymus cancer	0.018	0.018	CcSEcCtD
Bexarotene—Hypothyroidism—Octreotide—thymus cancer	0.0161	0.0161	CcSEcCtD
Bexarotene—Redness—Octreotide—thymus cancer	0.0153	0.0153	CcSEcCtD
Bexarotene—Seborrhoeic dermatitis—Octreotide—thymus cancer	0.0152	0.0152	CcSEcCtD
Bexarotene—Neuritis—Octreotide—thymus cancer	0.0139	0.0139	CcSEcCtD
Bexarotene—Herpes zoster—Octreotide—thymus cancer	0.0137	0.0138	CcSEcCtD
Bexarotene—Coagulopathy—Octreotide—thymus cancer	0.0133	0.0133	CcSEcCtD
Bexarotene—Petechiae—Octreotide—thymus cancer	0.0126	0.0126	CcSEcCtD
Bexarotene—Endocrine disorder—Octreotide—thymus cancer	0.0125	0.0125	CcSEcCtD
Bexarotene—Acne—Octreotide—thymus cancer	0.0123	0.0123	CcSEcCtD
Bexarotene—Neoplasm malignant—Octreotide—thymus cancer	0.0121	0.0121	CcSEcCtD
Bexarotene—Breast pain—Octreotide—thymus cancer	0.0119	0.0119	CcSEcCtD
Bexarotene—Jaundice cholestatic—Octreotide—thymus cancer	0.0118	0.0118	CcSEcCtD
Bexarotene—Viral infection—Octreotide—thymus cancer	0.0114	0.0115	CcSEcCtD
Bexarotene—Cellulitis—Octreotide—thymus cancer	0.0114	0.0114	CcSEcCtD
Bexarotene—Arthropathy—Octreotide—thymus cancer	0.0114	0.0114	CcSEcCtD
Bexarotene—Hyperbilirubinaemia—Octreotide—thymus cancer	0.0114	0.0114	CcSEcCtD
Bexarotene—Herpes simplex—Octreotide—thymus cancer	0.0112	0.0112	CcSEcCtD
Bexarotene—Phosphatase alkaline increased—Octreotide—thymus cancer	0.0103	0.0104	CcSEcCtD
Bexarotene—Hyperkalaemia—Octreotide—thymus cancer	0.0102	0.0102	CcSEcCtD
Bexarotene—Eructation—Octreotide—thymus cancer	0.0102	0.0102	CcSEcCtD
Bexarotene—Candida infection—Octreotide—thymus cancer	0.00987	0.00989	CcSEcCtD
Bexarotene—Neuropathy—Octreotide—thymus cancer	0.00971	0.00973	CcSEcCtD
Bexarotene—Cramps of lower extremities—Octreotide—thymus cancer	0.0095	0.00952	CcSEcCtD
Bexarotene—Urine output increased—Octreotide—thymus cancer	0.00935	0.00937	CcSEcCtD
Bexarotene—Mouth ulceration—Octreotide—thymus cancer	0.00935	0.00937	CcSEcCtD
Bexarotene—Blood alkaline phosphatase increased—Octreotide—thymus cancer	0.00863	0.00864	CcSEcCtD
Bexarotene—Polyuria—Octreotide—thymus cancer	0.00855	0.00856	CcSEcCtD
Bexarotene—Gastroenteritis—Octreotide—thymus cancer	0.00847	0.00848	CcSEcCtD
Bexarotene—Deafness—Octreotide—thymus cancer	0.00839	0.00841	CcSEcCtD
Bexarotene—Cardiac failure congestive—Octreotide—thymus cancer	0.00828	0.00829	CcSEcCtD
Bexarotene—Arthritis—Octreotide—thymus cancer	0.00772	0.00774	CcSEcCtD
Bexarotene—Osteoarthritis—Octreotide—thymus cancer	0.00751	0.00752	CcSEcCtD
Bexarotene—Dehydration—Octreotide—thymus cancer	0.00698	0.00699	CcSEcCtD
Bexarotene—Dry skin—Octreotide—thymus cancer	0.00688	0.00689	CcSEcCtD
Bexarotene—Muscular weakness—Octreotide—thymus cancer	0.00662	0.00663	CcSEcCtD
Bexarotene—Abdominal distension—Octreotide—thymus cancer	0.00653	0.00654	CcSEcCtD
Bexarotene—Influenza—Octreotide—thymus cancer	0.00649	0.0065	CcSEcCtD
Bexarotene—Pancreatitis—Octreotide—thymus cancer	0.00636	0.00637	CcSEcCtD
Bexarotene—Bronchitis—Octreotide—thymus cancer	0.00624	0.00625	CcSEcCtD
Bexarotene—Dysuria—Octreotide—thymus cancer	0.00607	0.00608	CcSEcCtD
Bexarotene—Pollakiuria—Octreotide—thymus cancer	0.00599	0.006	CcSEcCtD
Bexarotene—Weight increased—Octreotide—thymus cancer	0.0059	0.00591	CcSEcCtD
Bexarotene—Weight decreased—Octreotide—thymus cancer	0.00587	0.00588	CcSEcCtD
Bexarotene—Hyperglycaemia—Octreotide—thymus cancer	0.00585	0.00586	CcSEcCtD
Bexarotene—Pneumonia—Octreotide—thymus cancer	0.00582	0.00583	CcSEcCtD
Bexarotene—Neuropathy peripheral—Octreotide—thymus cancer	0.00567	0.00568	CcSEcCtD
Bexarotene—Jaundice—Octreotide—thymus cancer	0.00564	0.00565	CcSEcCtD
Bexarotene—Urinary tract infection—Octreotide—thymus cancer	0.00562	0.00563	CcSEcCtD
Bexarotene—Conjunctivitis—Octreotide—thymus cancer	0.00562	0.00563	CcSEcCtD
Bexarotene—Haematuria—Octreotide—thymus cancer	0.00552	0.00552	CcSEcCtD
Bexarotene—Epistaxis—Octreotide—thymus cancer	0.00546	0.00547	CcSEcCtD
Bexarotene—Sinusitis—Octreotide—thymus cancer	0.00543	0.00544	CcSEcCtD
Bexarotene—Rhinitis—Octreotide—thymus cancer	0.00521	0.00521	CcSEcCtD
Bexarotene—Hypoaesthesia—Octreotide—thymus cancer	0.00517	0.00518	CcSEcCtD
Bexarotene—Pharyngitis—Octreotide—thymus cancer	0.00515	0.00516	CcSEcCtD
Bexarotene—Oedema peripheral—Octreotide—thymus cancer	0.00512	0.00512	CcSEcCtD
Bexarotene—Tinnitus—Octreotide—thymus cancer	0.00484	0.00485	CcSEcCtD
Bexarotene—Cardiac disorder—Octreotide—thymus cancer	0.00482	0.00483	CcSEcCtD
Bexarotene—Arrhythmia—Octreotide—thymus cancer	0.00464	0.00465	CcSEcCtD
Bexarotene—Alopecia—Octreotide—thymus cancer	0.00459	0.0046	CcSEcCtD
Bexarotene—Malnutrition—Octreotide—thymus cancer	0.00452	0.00453	CcSEcCtD
Bexarotene—Erythema—Octreotide—thymus cancer	0.00452	0.00453	CcSEcCtD
Bexarotene—Flatulence—Octreotide—thymus cancer	0.00445	0.00446	CcSEcCtD
Bexarotene—Tension—Octreotide—thymus cancer	0.00444	0.00444	CcSEcCtD
Bexarotene—Nervousness—Octreotide—thymus cancer	0.00439	0.0044	CcSEcCtD
Bexarotene—Back pain—Octreotide—thymus cancer	0.00437	0.00438	CcSEcCtD
Bexarotene—Muscle spasms—Octreotide—thymus cancer	0.00435	0.00435	CcSEcCtD
Bexarotene—Ill-defined disorder—Octreotide—thymus cancer	0.00419	0.0042	CcSEcCtD
Bexarotene—Anaemia—Octreotide—thymus cancer	0.00418	0.00419	CcSEcCtD
Bexarotene—Agitation—Octreotide—thymus cancer	0.00415	0.00416	CcSEcCtD
Bexarotene—Malaise—Octreotide—thymus cancer	0.00408	0.00408	CcSEcCtD
Bexarotene—Vertigo—Octreotide—thymus cancer	0.00406	0.00407	CcSEcCtD
Bexarotene—Syncope—Octreotide—thymus cancer	0.00405	0.00406	CcSEcCtD
Bexarotene—Palpitations—Octreotide—thymus cancer	0.00399	0.004	CcSEcCtD
Bexarotene—Loss of consciousness—Octreotide—thymus cancer	0.00397	0.00398	CcSEcCtD
Bexarotene—Cough—Octreotide—thymus cancer	0.00394	0.00395	CcSEcCtD
Bexarotene—Hypertension—Octreotide—thymus cancer	0.0039	0.00391	CcSEcCtD
Bexarotene—Arthralgia—Octreotide—thymus cancer	0.00385	0.00385	CcSEcCtD
Bexarotene—Chest pain—Octreotide—thymus cancer	0.00385	0.00385	CcSEcCtD
Bexarotene—Myalgia—Octreotide—thymus cancer	0.00385	0.00385	CcSEcCtD
Bexarotene—Anxiety—Octreotide—thymus cancer	0.00384	0.00384	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00382	0.00383	CcSEcCtD
Bexarotene—Discomfort—Octreotide—thymus cancer	0.0038	0.00381	CcSEcCtD
Bexarotene—Dry mouth—Octreotide—thymus cancer	0.00376	0.00377	CcSEcCtD
Bexarotene—Oedema—Octreotide—thymus cancer	0.00369	0.0037	CcSEcCtD
Bexarotene—Infection—Octreotide—thymus cancer	0.00367	0.00367	CcSEcCtD
Bexarotene—Shock—Octreotide—thymus cancer	0.00363	0.00364	CcSEcCtD
Bexarotene—Nervous system disorder—Octreotide—thymus cancer	0.00362	0.00362	CcSEcCtD
Bexarotene—Thrombocytopenia—Octreotide—thymus cancer	0.00361	0.00362	CcSEcCtD
Bexarotene—Tachycardia—Octreotide—thymus cancer	0.0036	0.00361	CcSEcCtD
Bexarotene—Skin disorder—Octreotide—thymus cancer	0.00358	0.00359	CcSEcCtD
Bexarotene—Hyperhidrosis—Octreotide—thymus cancer	0.00357	0.00357	CcSEcCtD
Bexarotene—Anorexia—Octreotide—thymus cancer	0.00352	0.00352	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00336	0.00337	CcSEcCtD
Bexarotene—Insomnia—Octreotide—thymus cancer	0.00334	0.00334	CcSEcCtD
Bexarotene—Paraesthesia—Octreotide—thymus cancer	0.00331	0.00332	CcSEcCtD
Bexarotene—Dyspnoea—Octreotide—thymus cancer	0.00329	0.00329	CcSEcCtD
Bexarotene—Somnolence—Octreotide—thymus cancer	0.00328	0.00329	CcSEcCtD
Bexarotene—Dyspepsia—Octreotide—thymus cancer	0.00325	0.00325	CcSEcCtD
Bexarotene—Decreased appetite—Octreotide—thymus cancer	0.00321	0.00321	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Octreotide—thymus cancer	0.00319	0.00319	CcSEcCtD
Bexarotene—Fatigue—Octreotide—thymus cancer	0.00318	0.00319	CcSEcCtD
Bexarotene—Pain—Octreotide—thymus cancer	0.00315	0.00316	CcSEcCtD
Bexarotene—Constipation—Octreotide—thymus cancer	0.00315	0.00316	CcSEcCtD
Bexarotene—Feeling abnormal—Octreotide—thymus cancer	0.00304	0.00305	CcSEcCtD
Bexarotene—Gastrointestinal pain—Octreotide—thymus cancer	0.00302	0.00302	CcSEcCtD
Bexarotene—Body temperature increased—Octreotide—thymus cancer	0.00292	0.00292	CcSEcCtD
Bexarotene—Abdominal pain—Octreotide—thymus cancer	0.00292	0.00292	CcSEcCtD
Bexarotene—Hypersensitivity—Octreotide—thymus cancer	0.00272	0.00272	CcSEcCtD
Bexarotene—Asthenia—Octreotide—thymus cancer	0.00265	0.00265	CcSEcCtD
Bexarotene—Pruritus—Octreotide—thymus cancer	0.00261	0.00261	CcSEcCtD
Bexarotene—Diarrhoea—Octreotide—thymus cancer	0.00252	0.00253	CcSEcCtD
Bexarotene—Dizziness—Octreotide—thymus cancer	0.00244	0.00244	CcSEcCtD
Bexarotene—Vomiting—Octreotide—thymus cancer	0.00235	0.00235	CcSEcCtD
Bexarotene—Rash—Octreotide—thymus cancer	0.00233	0.00233	CcSEcCtD
Bexarotene—Dermatitis—Octreotide—thymus cancer	0.00232	0.00233	CcSEcCtD
Bexarotene—Headache—Octreotide—thymus cancer	0.00231	0.00232	CcSEcCtD
Bexarotene—Nausea—Octreotide—thymus cancer	0.00219	0.0022	CcSEcCtD
Bexarotene—RXRG—neck—thymus cancer	0.000438	0.265	CbGeAlD
Bexarotene—RXRG—pituitary gland—thymus cancer	0.000242	0.146	CbGeAlD
Bexarotene—RXRB—cardiac atrium—thymus cancer	0.000233	0.141	CbGeAlD
Bexarotene—RXRG—thyroid gland—thymus cancer	0.000209	0.126	CbGeAlD
Bexarotene—RXRB—thyroid gland—thymus cancer	0.000196	0.119	CbGeAlD
Bexarotene—RXRB—lung—thymus cancer	0.000178	0.108	CbGeAlD
Bexarotene—CYP2C9—hematopoietic system—thymus cancer	9.01e-05	0.0544	CbGeAlD
Bexarotene—CYP3A4—hematopoietic system—thymus cancer	6.87e-05	0.0415	CbGeAlD
